THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. AMENDED AND RESTATED MASTER SERVICES AGREEMENTMaster Services Agreement • August 10th, 2009 • Novavax Inc • Biological products, (no disgnostic substances)
Contract Type FiledAugust 10th, 2009 Company IndustryThis Master Services Agreement, dated as of June 29, 2009 (the “Effective Date”), is between Cadila Pharmaceuticals Limited, a company incorporated under the laws of India having its registered office at “Cadila Corporate Campus, Sarkhej — Dholka Road, Bhat, Ahmedabad-382210, Gujarat, India (“Cadila”), and Novavax, Inc., a Delaware corporation having its principal place of business at 9920 Belward Campus Drive, Rockville, Maryland, 20850, United States (“Novavax”).
THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. MASTER SERVICES AGREEMENTMaster Services Agreement • May 11th, 2009 • Novavax Inc • Biological products, (no disgnostic substances) • England
Contract Type FiledMay 11th, 2009 Company Industry JurisdictionThis Master Services Agreement, dated as of March 31, 2009 (the “Effective Date”), is between Cadila Pharmaceuticals Limited, a company incorporated under the laws of India having its registered office at “Cadila Corporate Campus, Sarkhej — Dholka Road, Bhat, Ahmedabad-382210, Gujarat, India (“Cadila”), and Novavax, Inc., a Delaware corporation having its principal place of business at 9920 Belward Campus Drive, Rockville, Maryland, 20850, United States (“Novavax”).